Stocks and Finance

Quidel

Quidel 4/2/2012

19:21 : Quidel Receives CE Mark for Its Direct Specimen Rapid PCR Test for Toxigeni - SAN DIEGO, CA--(Marketwire - Apr 2, 2012) - Quidel Corporation (NASDAQ: QDEL) announced today that it received CE mark for the Quidel MolecularT Direct C. difficile Tox A/B assay for the detection of toxigenic Clostridium difficile ...
Source : marketwire-com

Quidel 3/27/2012

23:05 : Quidel Receives CE Mark for Its AmpliVue(TM) Hand-Held Molecular Diagnostic - SAN DIEGO, CA--(Marketwire - Mar 27, 2012) - Quidel Corporation (NASDAQ: QDEL), announced today that it received CE mark for the AmpliVue C. difficile assay, its non-instrumented molecular test for the detection of toxigenic Clostridium ...
Source : marketwire-com

Quidel 3/12/2012

19:20 : Quidel Receives CE Mark for Its Molecular Diagnostic Test for Respiratory ... - SAN DIEGO, CA--(Marketwire - Mar 12, 2012) - Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cell-based virology assays, announced today that it has received the CE Mark for the Quidel ...
Source : marketwire-com

Quidel 12/27/2011

07:40 : Quidel (QDEL) announced over the weekend that it received FDA clearance ... - Quidel (QDEL) announced over the weekend that it received FDA clearance for the sale diagnostic testing products related to detecting influenza and human metapneumovirus. William Blair (Outperform) sees the announcements as evidence Quidel ...
Source : seekingalpha-com

Quidel 12/23/2011

21:42 : Quidel Receives FDA Clearance for Its Quidel Molecular Human Metapneumoviru - SAN DIEGO, CA--(Marketwire - Dec 23, 2011) - Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it has received 510(k) clearance from the ...
Source : marketwire-com
21:41 : Quidel Receives FDA Clearance for Its Quidel Molecular Influenza A+B Assay - SAN DIEGO, CA--(Marketwire - Dec 23, 2011) - Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions and cellular-based virology assays, announced today that it has received 510(k) clearance from the United ...
Source : marketwire-com

Quidel 10/25/2011

15:05 : Quidel Reports Third Quarter 2011 Financial Results - SAN DIEGO, CA--(Marketwire - Oct 25, 2011) - Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today financial results for the third quarter ended September ...
Source : marketwire-com

Quidel 7/19/2011

18:27 : Quidel to Hold Second Quarter 2011 Financial Results Conference Call on ... - SAN DIEGO, CA--(Marketwire - Jul 19, 2011) - Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release second quarter 2011 financial results after market ...
Source : marketwire-com
actualidad Quidel -


Medical Supplies

Pharmaceuticals

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts